(1 - 7 from 10
)
Izmir Biomedicine and Genome Center
www.ibg.edu.tr
· Dr. Gonul Velicelebi, founder and CEO of Camino Pharma, San Diego, CA, delivered a speech titled "Discovery and Development of Small Molecule Drugs for CNS Diseases" on 5th of October at IBG. In her speech, she talked about functionally modulators of metabotropic glutamate receptors (mGlus), which are a family of G protein-coupled ...
$11.4 million NIH grant advances drug to treat …
www.newswise.com
“Incredibly, it has been 14 years since FDA approved the last drug treatment for nicotine addiction,” says principal investigator Gonul Velicelebi, Ph.D., CEO and co-founder of Camino Pharma ...
CalciMedica Enters Two Deals to Enhance Drug Development ...www.genengnews.com › News
www.genengnews.com
... as gatekeepers of an essential pathway for immune cell function,” Gonul Velicelebi, Ph.D, president and CEO of CalciMedica, points out.
CalciMedica Enters Two Deals to Enhance Drug Development in...
www.genengnews.com
"STIM1 and Orai1 function together as gatekeepers of an essential pathway for immune cell function,” Gonul Velicelebi, Ph.D, president and CEO of CalciMedica ...
sorted by relevance / date